Is the Prostate Cancer Testing Protocol Alarming? Insights from Hislop

Shaka Hislop, former Premier League goalkeeper and Trinidad and Tobago international, has highlighted the alarming lack of routine prostate cancer testing in the UK, emphasising that the current protocols are insufficient. His diagnosis in 2024, after requesting a prostate-specific antigen (PSA) test, underscores the need for standardised screening to improve early detection and treatment, particularly in high-risk communities.

Last updated: 22 October 2023 (BST)

What’s happening now

Shaka Hislop's recent remarks concerning prostate cancer testing protocols in the UK bring attention to a significant health issue. Hislop, diagnosed in 2024, has voiced concerns about the lack of regular and standardised testing for prostate cancer, particularly for men under 50 and those without a family history of the disease. The UK's National Health Service (NHS) typically offers PSA testing only to men over the age of 50 or those exhibiting symptoms, which Hislop argues is insufficient given the rising incidence of prostate cancer, especially among black males.

Key takeaways

• Shaka Hislop was diagnosed with prostate cancer in 2024 after requesting a PSA test.
• The NHS does not routinely offer PSA testing, which limits early detection.
• Prostate Cancer UK reports that one in eight men will be diagnosed with the disease, and the risk is higher for black males at one in four.

Timeline: how we got here

The conversation around prostate cancer testing has evolved significantly in recent years:

• 2024: Shaka Hislop diagnosed with prostate cancer after requesting a PSA test during an examination in the USA.
• 2024: Sir Chris Hoy, a six-time Olympic gold medalist, also diagnosed with prostate cancer, advocates for changes in testing protocols.
• November 2025: UK National Screening Committee decides against recommending mass screening for prostate cancer, citing reliability issues with the main screening test.

What’s new vs what’s known

New today/this week

Hislop's recent statements have reignited discussions about prostate cancer testing protocols in the UK, with a particular focus on the impact of these protocols on minority communities. His personal experience and advocacy for standardised testing highlight a growing concern among former athletes regarding health inequalities.

What was already established

Prior to Hislop's diagnosis, it was already known that prostate cancer is a significant health concern in the UK, particularly affecting black males at a disproportionately higher rate. The NHS's conservative testing approach has been critiqued for potentially missing early diagnoses in younger men or those without family histories.

Impact for the UK

Consumers and households

For families and individuals, the lack of routine PSA testing can lead to late diagnoses, which may result in more aggressive treatments and poorer outcomes. The emotional and financial implications of prostate cancer can be considerable, especially for those who may not even be aware of their increased risk.

Businesses and jobs

Increased awareness and advocacy for prostate cancer screening could lead to more discussions around workplace health policies. Companies might need to consider health initiatives that address the importance of regular health checks, particularly for male employees in high-risk categories.

Policy and regulation

The ongoing dialogue around prostate cancer testing highlights the need for policy reviews within the NHS. Health Secretary Wes Streeting has indicated that the government is weighing evidence to potentially alter current testing recommendations, particularly in light of evident health disparities among different ethnic groups.

Numbers that matter

• 1 in 8 men will be diagnosed with prostate cancer during their lifetime.
• 1 in 4 black men will be diagnosed with prostate cancer, significantly higher than the national average.
• PSA testing is typically recommended by the NHS only for men over 50 unless symptoms are present.
• Sir Chris Hoy, diagnosed in 2024, faced a dire prognosis, illustrating the severity of undiagnosed prostate cancer.

Definitions and jargon buster

• Prostate-Specific Antigen (PSA): A protein produced by the prostate gland, elevated levels in the blood can indicate prostate cancer.
• PSA Test: A blood test used to screen for prostate abnormalities, including cancer.

How to think about the next steps

Near term (0–4 weeks)

Individuals should consider discussing prostate cancer screening with their healthcare providers, particularly if they are in a high-risk category.

Medium term (1–6 months)

Watch for potential changes in NHS guidelines regarding PSA testing, especially as discussions continue around health inequalities.

Signals to watch

• Updates from the UK National Screening Committee regarding prostate cancer screening recommendations.
• Public health campaigns focused on raising awareness about prostate cancer risk factors.

Practical guidance

Do

• Request a PSA test if you are over 50 or have a family history of prostate cancer.
• Educate yourself on the signs and symptoms of prostate cancer.

Don’t

• Don’t ignore changes in urinary habits or other potential symptoms.
• Don’t assume you are not at risk based on age or family history alone.

Checklist

• Discuss prostate cancer risks with your doctor.
• Consider lifestyle changes that may reduce cancer risk, such as diet and exercise.
• Stay informed about prostate cancer research and guidelines.

Risks, caveats, and uncertainties

While Hislop's advocacy sheds light on an important health issue, there are risks associated with over-diagnosis and unnecessary treatment, which the NHS has highlighted. The balance between adequate screening and avoiding overtreatment remains a contentious point, and ongoing research is essential to establish effective protocols.

Bottom line

Shaka Hislop’s experience with prostate cancer highlights the urgent need for changes in the UK’s prostate cancer screening protocols. By advocating for routine PSA testing, particularly among high-risk groups, there is a potential for earlier diagnosis and better outcomes, ultimately saving lives and improving the quality of life for those affected.

FAQs

What is prostate cancer?

Prostate cancer is a form of cancer that occurs in the prostate, a small walnut-shaped gland in males that produces seminal fluid. Early detection is crucial for effective treatment.

How can I get tested for prostate cancer in the UK?

Currently, the NHS recommends PSA testing for men over 50 or those with symptoms. However, you can discuss your concerns with your GP to explore your options for testing.

What are the risk factors for prostate cancer?

Risk factors include age (men over 50), family history of prostate cancer, and ethnicity, with black men facing a significantly higher risk.